CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

cannabis

Botanicalexperimental

Cannabis, commonly known as marijuana, weed, pot, and ganja, among other names, is a non-chemically uniform psychoactive drug from the Cannabis plant. Native to Central or South Asia, cannabis has been used as a drug for both recreational and entheogenic purposes and in various traditional medicines for centuries. Tetrahydrocannabinol (THC) is the main psychoactive component of cannabis, which is one of the 483 known compounds in the plant, including at least 65 other cannabinoids, such as cannabidiol (CBD). Cannabis can be used by smoking, vaporizing, within food, or as an extract. — Wikipedia

Clinical trial activity

229 trials · 177 clinical orgs · 0 marketing orgs

Phase 1
101
Phase 2
113
Phase 3
33
Phase 4
3

Earliest trial started Sep 1, 2001 (NCT00255580)

Timeline

2000s

  1. Jan 1, 2001

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2001

    Earliest Phase 3 Sponsor(trial)

  3. Jan 1, 2003

    Earliest Phase 2 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • cannabis
  • cannabis
  • cannabis based medicine extract
  • cannabis indica
  • cannabis oil
  • cannabis sativa extract
  • gw-2000-02
  • marijuana
  • sativex

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07257939Phase 3Jul 1, 2026Fenix Innovation Group, Neurotech USA
NCT07257978Phase 2/Phase 3 (Phase 3)Jul 1, 2026Fenix Innovation Group, Neurotech USA
NCT06956014Phase 3Mar 31, 2026Vertanical GmbH
NCT07224698Phase 2Feb 1, 2026Multidisciplinary Association for Psychedelic Studies
NCT07216690Phase 2Jan 5, 2026Johns Hopkins University, National Institute on Drug Abuse (NIDA)
NCT07214155Phase 1Jan 1, 2026Johns Hopkins University, National Institute on Drug Abuse (NIDA)
NCT07224932Phase 2Dec 19, 2025University of Colorado, Denver
NCT07105449N/AOct 1, 2025National Institute on Drug Abuse (NIDA), University of Toronto
NCT07091084N/AJul 15, 2025Memorial Sloan-Kettering Cancer Center
NCT06859710Phase 1Jun 1, 2025University of California, Los Angeles
NCT06755346Phase 1Apr 1, 2025Washington State University
NCT06863740N/AMar 31, 2025University of Toronto
NCT06334016Early Phase 1 (Phase 1)Mar 27, 2025National Institute on Drug Abuse (NIDA), State University of New York, Buffalo
NCT06807762Phase 1Mar 10, 2025GreenCare Pharma
NCT06435299Phase 3Jan 1, 2025University of Western Brittany
NCT06351540Phase 1Jan 1, 2025Johns Hopkins University, National Institute on Drug Abuse (NIDA)
NCT06713447Phase 1Dec 1, 2024CMAX Clinical Research, Fenix Innovation Group, Neurotech USA
NCT06595576N/AOct 1, 2024University of Toronto
NCT06526208Phase 2Oct 1, 2024Southwest Autism Research & Resource Center
NCT06293040Phase 1Sep 26, 2024Johns Hopkins University, National Institute on Drug Abuse (NIDA)
Showing 20 of 229 trials
Page 1 / 12

Organizations

Research & Development (177)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
National Institute on Drug Abuse (NIDA)Government38242004
Columbia UniversityAcademic/Hospital232122004
University of California, San DiegoAcademic/Hospital201942001
Johns Hopkins UniversityAcademic/Hospital151522013
University of TorontoAcademic/Hospital141142018
Apurano Pharmaceuticals GmbHFor profit8812023
Fenix Innovation GroupFor profit7732021
Neurotech USAFor profit7032021
University of California, San FranciscoAcademic/Hospital7432002
Yale UniversityAcademic/Hospital7532016
Vertanical GmbHFor profit6632021
Technion UniversityAcademic/Hospital5232013
University of California, DavisAcademic/Hospital5222003
University of ConnecticutAcademic/Hospital5232016
University of KentuckyAcademic/Hospital5522019
Hebrew UniversityAcademic/Hospital4422017
NHTSAGovernment4022012
Research Foundation for Mental Hygiene, Inc.Academic/Hospital4012006
Tel Aviv UniversityAcademic/Hospital4432010
University of California, Los AngelesAcademic/Hospital4412020
177 organizations
Page 1 / 9